For acam 2000 vaccines
Ended Awarded Last action
- Contract number
- HHSD2002008249590007
- Awardee
-
Emergent Biodefense Operations Lansing LLC UEI MUM1EGCDWZJ4
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $37,890,000
Award facts
- Opportunity
-
- 2006N08476 Solicitation number
- Contract value 100% obligated
- $37,890,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- CDC Pittsburgh Centers for Disease Control and Prevention, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Transfer Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $37,890,000 |
About this award
This contract award, valued at $37,890,000, was issued by the Centers for Disease Control and Prevention (CDC) to Emergent BioDefense Operations Lansing LLC for the delivery of ACAM 2000 vaccines. ACAM 2000 is the only Food and Drug Administration (FDA)-licensed vaccine for the prevention of smallpox disease, a critical component of the U.S. government's strategic national stockpile.
The contract, awarded on September 30, 2015, is a firm-fixed-price delivery order with an ultimate completion date of March 31, 2019. This award is not associated with a set-aside program. Emergent BioDefense, a for-profit manufacturer of medical countermeasures and biopharmaceuticals, has a history of producing vaccines and therapeutics for public health threats, particularly in the area of biodefense. This contract award highlights the company's crucial role in supporting the U.S. government's national biodefense efforts by ensuring the continuous availability of the ACAM 2000 vaccine for the strategic national stockpile.
Quick answers
Who was awarded contract HHSD2002008249590007?
HHSD2002008249590007 was awarded to Emergent Biodefense Operations Lansing LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2015.
How much is contract HHSD2002008249590007 worth?
The government has obligated $37,890,000 on HHSD2002008249590007.
Which agency awarded contract HHSD2002008249590007?
Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) awarded HHSD2002008249590007, with funding from CDC Pittsburgh (Centers for Disease Control and Prevention).
Is contract HHSD2002008249590007 an order under another contract?
Yes. HHSD2002008249590007 is a delivery order under HHSD200200824959I, an indefinite delivery contract.
Was contract HHSD2002008249590007 competed?
The extent of competition for HHSD2002008249590007 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award